Form 4: Mark A. Smith Acquires 375,000 Options in NioCorp (NB)
Rhea-AI Filing Summary
Mark A. Smith, President & CEO and a Director of NioCorp Developments Ltd. (NB), acquired 375,000 employee stock options on 08/18/2025. The options have an exercise price of $4.35 and 34% vested on the grant date; the remainder vests in equal installments each anniversary through 08/18/2027. The options are exercisable beginning 08/19/2025 and expire 08/19/2030. After the transaction, Mr. Smith beneficially owns 375,000 options reported as direct ownership.
Positive
- Reporting person is identified as President & CEO and Director, providing clear corporate role context.
- Grant of 375,000 employee stock options dated 08/18/2025 is explicitly recorded.
- Exercise price of $4.35 and full post-transaction beneficial ownership of 375,000 options are disclosed.
- Vesting schedule stated: 34% vested at grant with remaining vesting in equal annual installments through 08/18/2027.
Negative
- None.
Insights
TL;DR: Insider option grant to CEO/director with multi-year vesting; confirms executive equity compensation.
The Form 4 documents an 08/18/2025 acquisition of 375,000 employee stock options by Mark A. Smith, who is identified as both President & CEO and a director. The filing reports a direct beneficial ownership of 375,000 options, an exercise price of $4.35, an exercisability start date of 08/19/2025 and an expiration of 08/19/2030. The vesting schedule: 34% vested at grant, with the remainder vesting in equal annual installments to 08/18/2027. This filing transparently records the equity-based compensation event and the relevant mechanics.
TL;DR: Option grant structure: partial immediate vesting plus annual vesting to 2027; five-year contractual life to 2030.
The reported derivative security is an employee stock option with a $4.35 exercise price and a stated grant on 08/18/2025. The filing specifies that 34% of the options vested on the grant date and the remainder vests annually until 08/18/2027. The options are exercisable starting 08/19/2025 and expire 08/19/2030. The Form 4 records direct beneficial ownership of 375,000 options following the acquisition and provides no additional amendments or joint filers.